Deepak Cyril D'Souza

Professor

Yale University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Deepak Cyril D'Souza is a Professor at Yale University, USA. His research focuses on the neurobiological and pharmacological aspects of psychiatric disorders, particularly in relation to cannabis, cannabinoids, and psychosis. Recent publications include studies on cannabinoid receptor availability in PTSD, the effects of THC and ethanol, and the safety of dimethyltryptamine in depressive disorders.

Articles (8)

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (5)

Angus Nairn

Professor

Yale University

UNITED STATES

View details

Edoardo Spinazzola

King’s College London

UNITED KINGDOM

View details

Ashley Schnakenberg Martin

Yale University

UNITED STATES

View details

Rolando Garcia-Milian

Lecturer in Epidemiology

Yale School of Public Health

UNITED STATES

View details

Nabeel Nabulsi

• Assistant Professor of Clinical Radiochemistry, Chief Radiochemist

Columbia University Irving Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Deepak Cyril D'Souza

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Cannabinoid 1 receptor availability in posttraumatic stress disorder: A positron emission tomography study

Peripheral signature of altered synaptic integrity in young onset cannabis use disorder: A proteomic study of circulating extracellular vesicles

Preliminary study of the interactive effects of THC and ethanol on self-reported ability and simulated driving, subjective effects, and cardiovascular responses

Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis

Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder

Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophrenia

Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder

A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants

Collaborators (5)

Angus Nairn

Edoardo Spinazzola

Ashley Schnakenberg Martin

Rolando Garcia-Milian

Nabeel Nabulsi

Make your next move.